Skip to main content
. 2015 Aug 26;10(8):e0133832. doi: 10.1371/journal.pone.0133832

Table 3. Effects of the interventions on the primary outcome compared with control, by facility type.

Outcome Study arm Clusters Individual-level prevalence Cluster-level prevalence Stratified risk difference
Public Private Public Private Public Private Public Private
n n n/N (%) n/N (%) Mean (SD) Mean (SD) RD(95% CI) RD(95% CI)
Febrile patients tested for malaria Control 6 6 118/229 (51.5%) 314/1307 (24.0%) 50.0% (32) 17.9% (15) 0 0
Provider 10 7 230/325 (70.8%) 186/1507 (12.3%) 69.2% (21) 16.9% (12) 22.7%(-5.6, 51.0) 0.5%(-15.2, 16.2)
Provider-school 7 7 122/213 (57.3%) 109/1283 (8.5%) 61.8% (28) 11.1% (12) 13.1%(-16.7, 42.9) -6.1%(-21.5, 9.3)
Test positive patients receiving ACT Control 6 6 45/66 (68%) 193/254 (76%) 61.9% (34) 66.5% (23) 0 0
Provider 10 7 40/73 (55%) 55/69 (80%) 57.3% (36) 51.3% (35) -8.3%(-46.7, 30.0) 3.2%(-33.7, 40.2)
Provider-school 7 7 16/37 (43%) 43/61 (70%) 48.6% (32) 64.3% (36) -13.4%(-55.2, 28.5) -2.2%(-34.6, 30.3)
Test negative patients receiving an antimalarial Control 6 6 18/52 (35%) 33/60 (55%) 41.1% (41) 73.0% (29) 0 0
Provider 10 7 27/157 (17%) 67/117 (57%) 24.7% (32) 33.0% (33) -14.0%(-54.7, 26.7) -37.6%(-83.3, 8.3)
Provider-school 7 7 21/85 (25%) 40/48 (83%) 26.5% (38) 63.7% (41) -13.8%(-56.7, 29.1) -9.6%(-56.0, 36.7)
Treatment according to malaria guidelines Control 6 6 79/229 (34%) 220/1307 (17%) 33.3% (27) 11.8% (11) 0 0
Provider 10 7 170/325 (52%) 105/1507 (7%) 52.3% (28) 10.0% (8) 20.1%(-10.5, 50.8) -0.7%(-12.3, 11.0)
Provider-school 7 7 80/213 (38%) 51/1283 (4%) 40.7% (26) 6.4% (9) 7.8%(-24.6, 40.1) -4.9%(-16.3, 6.5)

TABLE NOTES

A cluster contributes to the analysis of public facilities if it has at least one such facility, and similarly for private. Clusters with at least one of each type contribute to both analyses.

The stratified risk differences were calculated as before, but separately for public and private facilities.